Search research articles
Contact Us
Filters
Showing results (271-280 of 301) with videos related to
Page
of 31
Sort By:
La Ricerca in Clinica E in Laboratorio
|
January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studies
G Parmiani, M L Sensi, A Balsari, et al.
Cancer Research
|
September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody
C Melani, M Figini, D Nicosia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma
E Bajetta, M Del Vecchio, R Mortarini, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study
A Balsari, R Marolda, C Gambacorti-Passerini, et al.
Tumori
|
June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients
N Cascinelli, F Belli, S Marchini, et al.
Cancer Research
|
February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy
L Rivoltini, P Squarcina, D J Loftus, et al.
International Journal of Cancer
|
November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigens
A J Bremers, S Andreola, E Leo, et al.
The Journal of Experimental Medicine
|
August 1, 1996
Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)
D J Loftus, C Castelli, T M Clay, et al.
Human Gene Therapy
|
October 20, 1996
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells
F Arienti, J Sulé-Suso, F Belli, et al.
Folia Biologica
|
January 1, 1996
Cytokine-based gene therapy of human tumors. An overview
G Parmiani, F Arienti, J Sulé-Suso, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 301) with videos related to
Sort By:
Page
of 31
La Ricerca in Clinica E in Laboratorio
|
January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studies
G Parmiani, M L Sensi, A Balsari, et al.
Cancer Research
|
September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody
C Melani, M Figini, D Nicosia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma
E Bajetta, M Del Vecchio, R Mortarini, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study
A Balsari, R Marolda, C Gambacorti-Passerini, et al.
Tumori
|
June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients
N Cascinelli, F Belli, S Marchini, et al.
Cancer Research
|
February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy
L Rivoltini, P Squarcina, D J Loftus, et al.
International Journal of Cancer
|
November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigens
A J Bremers, S Andreola, E Leo, et al.
The Journal of Experimental Medicine
|
August 1, 1996
Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)
D J Loftus, C Castelli, T M Clay, et al.
Human Gene Therapy
|
October 20, 1996
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells
F Arienti, J Sulé-Suso, F Belli, et al.
Folia Biologica
|
January 1, 1996
Cytokine-based gene therapy of human tumors. An overview
G Parmiani, F Arienti, J Sulé-Suso, et al.
Page
of 31